Companies / Ionis Pharmaceuticals Inc / Activity
Activity — Ionis Pharmaceuticals Inc
251 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | Klein Joseph III Director | Sell | Common Stock | $636.7K | -9K -41.09% | 12,445 <0.01% of shares | medium |
| Jan 16, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $634.4K | -8K -23.95% | 26,518 0.02% of shares | medium |
| Jun 1, 2026 | Berthelsen Spencer R Director | Sell | Common Stock | $605.4K | -8K -4.88% | 156,013 0.09% of shares | medium |
| Jun 15, 2026 | Berthelsen Spencer R Director | Sell | Common Stock | $587.9K | -8K -4.88% | 156,013 0.09% of shares | medium |
| Jan 30, 2026 | Hougen Elizabeth L Executive | Sell | Common Stock | $581.7K | -7K -5.00% | 132,881 0.08% of shares | medium |
| Mar 9, 2026 | Monia Brett P CEO | Sell | Common Stock | $547.1K | -7K -2.00% | 361,950 0.22% of shares | medium |
| Mar 3, 2026 | Klein Joseph III Director | Sell | Common Stock | $543.5K | -7K -36.10% | 12,026 <0.01% of shares | medium |
| Mar 3, 2026 | Bennett C Frank Executive | Exercise | Common Stock | $536.7K | +16K +16.37% | 117,017 0.07% of shares | low |
| Feb 2, 2026 | Bennett C Frank Executive | Exercise | Common Stock | $536.7K | +16K +20.50% | 96,756 0.06% of shares | low |
| Jan 16, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $523.2K | -7K -14.59% | 40,431 0.02% of shares | medium |
| Jan 30, 2026 | O'Neil Patrick R. Executive | Sell | Common Stock | $516.2K | -6K -7.91% | 71,983 0.04% of shares | medium |
| Jan 30, 2026 | Schneider Eugene Executive | Sell | Common Stock | $515.6K | -6K -8.14% | 69,702 0.04% of shares | medium |
| Jan 30, 2026 | Birchler Brian Executive | Sell | Common Stock | $513.0K | -6K -8.53% | 66,247 0.04% of shares | medium |
| Jan 30, 2026 | Swayze Eric Executive | Sell | Common Stock | $512.4K | -6K -11.46% | 47,747 0.03% of shares | medium |
| Feb 13, 2026 | Swayze Eric Executive | Sell | Common Stock | $509.4K | -6K -16.20% | 32,105 0.02% of shares | medium |
| Jan 7, 2026 | Devers Shannon L. Executive | Exercise | Common Stock | $489.8K | +9K +52.96% | 26,758 0.02% of shares | low |
| Jan 30, 2026 | Bennett C Frank Executive | Sell | Common Stock | $488.1K | -6K -5.54% | 100,293 0.06% of shares | medium |
| May 4, 2026 | Loscalzo Joseph Director | Exercise | Common Stock | $480.6K | +12K +25.37% | 59,298 0.04% of shares | low |
| Mar 3, 2026 | Klein Joseph III Director | Exercise | Common Stock | $480.6K | +12K +73.41% | 28,346 0.02% of shares | low |
| May 1, 2026 | Klein Joseph III Director | Exercise | Common Stock | $476.3K | +10K +91.80% | 21,125 0.01% of shares | low |
| Apr 1, 2026 | Klein Joseph III Director | Exercise | Common Stock | $456.7K | +12K +108.95% | 23,014 0.01% of shares | low |
| Mar 3, 2026 | Diaz Allene M. Director | Exercise | Common Stock | $456.7K | +12K +41.83% | 40,689 0.02% of shares | low |
| Jan 30, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $439.4K | -5K -10.44% | 45,413 0.03% of shares | medium |
| May 4, 2026 | Loscalzo Joseph Director | Exercise | Common Stock | $424.0K | +10K +17.41% | 69,619 0.04% of shares | low |
| Apr 1, 2026 | Klein Joseph III Director | Exercise | Common Stock | $424.0K | +10K +44.85% | 33,335 0.02% of shares | low |
| Mar 3, 2026 | Diaz Allene M. Director | Exercise | Common Stock | $424.0K | +10K +56.19% | 28,689 0.02% of shares | low |
| May 4, 2026 | Loscalzo Joseph Director | Exercise | Common Stock | $417.4K | +11K +30.19% | 47,298 0.03% of shares | low |
| Feb 11, 2026 | Parshall B Lynne Director | Sell | Common Stock | $413.6K | -5K -8.15% | 56,344 0.03% of shares | medium |
| Mar 19, 2026 | Schneider Eugene Executive | Sell | Common Stock | $412.5K | -6K -8.34% | 63,890 0.04% of shares | medium |
| Jan 2, 2026 | Swayze Eric Executive | Sell | Common Stock | $402.7K | -5K -14.41% | 30,453 0.02% of shares | medium |
| Mar 3, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $402.4K | -5K -17.76% | 23,296 0.01% of shares | medium |
| Apr 15, 2026 | Parshall B Lynne Director | Sell | Common Stock | $340.3K | -4K -7.93% | 51,878 0.03% of shares | medium |
| Mar 3, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $325.1K | -4K -9.02% | 41,317 0.02% of shares | medium |
| Jan 7, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $324.0K | -4K -17.96% | 17,494 0.01% of shares | medium |
| Jan 22, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $323.5K | -4K -15.00% | 22,541 0.01% of shares | medium |
| Jan 16, 2026 | Kordasiewicz Holly B. Executive | Sell | Common Stock | $313.3K | -4K -21.96% | 14,718 <0.01% of shares | medium |
| Jan 2, 2026 | Swayze Eric Executive | Exercise | Common Stock | $312.1K | +5K +16.83% | 35,578 0.02% of shares | low |
| Jan 7, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $292.8K | -3K -16.51% | 17,494 0.01% of shares | medium |
| Mar 3, 2026 | Devers Shannon L. Executive | Exercise | Common Stock | $226.6K | +7K +19.69% | 42,262 0.03% of shares | low |
| Jun 15, 2026 | Berthelsen Spencer R Director | Exercise | Common Stock | $195.4K | +8K +5.13% | 164,013 0.10% of shares | low |
| Jun 1, 2026 | Berthelsen Spencer R Director | Exercise | Common Stock | $195.4K | +8K +5.13% | 164,013 0.10% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Exercise | Common Stock | $190.8K | +6K +18.45% | 35,311 0.02% of shares | low |
| Jan 7, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $179.3K | -2K -10.72% | 17,494 0.01% of shares | medium |
| Mar 3, 2026 | Klein Joseph III Director | Exercise | Common Stock | $171.5K | +4K +14.11% | 32,346 0.02% of shares | low |
| Apr 1, 2026 | Klein Joseph III Director | Sell | Common Stock | $168.3K | -2K -16.75% | 11,014 <0.01% of shares | medium |
| Mar 3, 2026 | Baroldi Joseph Executive | Sell | Common Stock | $167.9K | -2K -32.27% | 4,383 <0.01% of shares | medium |
| Mar 10, 2026 | Jenne Kyle Executive | Exercise | Common Stock | $162.2K | +5K +39.91% | 16,389 <0.01% of shares | low |
| Mar 3, 2026 | Devers Shannon L. Executive | Exercise | Common Stock | $153.6K | +4K +14.43% | 29,811 0.02% of shares | low |
| Jan 7, 2026 | Devers Shannon L. Executive | Exercise | Common Stock | $143.9K | +4K +21.89% | 21,323 0.01% of shares | low |
| Jan 16, 2026 | Jenne Kyle Executive | Sell | Common Stock | $138.5K | -2K -10.01% | 16,389 <0.01% of shares | medium |